What's the difference between revaccinate and vaccinate?

Revaccinate


Definition:

  • (v. t.) To vaccinate a second time or again.

Example Sentences:

  • (1) This article provides an update of data on (1) the risk and degree of joint symptoms following vaccination and revaccination, (2) the duration of vaccine-induced immunity, (3) the protective effect of low levels of vaccine-induced antibody, and (4) the risks to the fetus following maternal vaccination.
  • (2) Since the importation of toxin-producing diphtheria bacteria is unavoidable and may occur at all times, universal active immunisation in childhood, as well as timely revaccination of adolescents and adults, are mandatory prophylactic measures to prevent new epidemics.
  • (3) As a result of the continuing threat of Venezuelan equine encephalomyelitis (VEE), a study was made to determine if revaccination against VEE (TC-83 vaccine) was feasible and if revaccination could be incorporated into other routine vaccination practices.
  • (4) Antibody titres were subsequently well maintained in both groups and did not reveal any need for regular revaccination.
  • (5) In the study of the dynamics of the development of skin reactivity to tuberculin some advantages of the sensitization of guinea pigs with live mycobacteria were revealed, while after the revaccination of the animals no development of secondary cell-mediated immune response was observed.
  • (6) BCG revaccination was given formerly to 20% of the age cohort but nowadays only 6% or 2% meet the criteria after receiving either Copenhagen or Glaxo BCG at birth.
  • (7) Inactivated influenza vaccines are classified according to the types of antihemagglutinin response after annual revaccination of people with inactivated influenza vaccines carried out for 3 successive years.
  • (8) These findings support current recommendations for measles booster revaccination of school-age children and adolescents.
  • (9) An increase in revaccination intervals was found to contribute to a more precise detection of primary tuberculosis contamination and larger (more than four times) BCG coverage of adolescents.
  • (10) After revaccination (one year later) with monovalent type 1 vaccine, the vaccine strain of type 1 poliovirus could be detected for 6 weeks and was present in the highest percentage of positive stool samples.
  • (11) Those revaccinated with bovine virus diarrhea showed an immediate response of small magnitude.
  • (12) Antibody levels increased up to 16 fold when revaccination was carried out.
  • (13) In this report, we investigated the efficacy of revaccination with hepatitis B vaccine in thirty-eight children after primary immunization.
  • (14) Based on this study, it is impossible to be sure that revaccination improved protective immunity, but the increase in tuberculin responsiveness, and recognition of environmental mycobacterial species may be indirect evidence supporting this conclusion.
  • (15) Specific antibodies were investigated in serums of chicks vaccinated with live vaccine and revaccinated with inactivated vaccine against the infectious bursal disease virus, using three methods.
  • (16) In the 1st stage, the response was 70.37%; nonresponder patients (n = 8) were treated with thymostimulin and revaccinated.
  • (17) Therefore, to eliminate measles in this age-group, clinicians must take the initiative to vaccinate or revaccinate patients.
  • (18) None of 80 Browning students who were vaccinated at less than 12 months of age and revaccinated at 15 months of age or older became infected.
  • (19) Three weeks after revaccination, all in group 1 and 30 (90%) of 33 in group 2 had developed a fourfold or greater rise in PRN antibody.
  • (20) Revaccination after 3 or 4 weeks had little effect, particularly with the attenuated vaccines.

Vaccinate


Definition:

  • (v. t.) To inoculate with the cowpox by means of a virus, called vaccine, taken either directly or indirectly from cows.

Example Sentences:

  • (1) We were able to detect genetic recombination between vaccine strains of PRV following in vitro or in vivo coinoculation of 2 strains of PRV.
  • (2) Attempts are now being made to use this increased understanding to produce effective killed vaccines that produce immune responses in the lung.
  • (3) We have measured the antibody specificities to the two polysaccharides in sera from asymptomatic group C meningococcal carriers and vaccinated adults by a new enzyme-linked immunosorbent assay (ELISA) procedure using methylated human serum albumin for coating the group C polysaccharide onto microtiter plates.
  • (4) The simultaneous administration of the yellow fever vaccine did not influence the titre of agglutinins induced by the classic cholera vaccine.
  • (5) Before carrier vaccines are applied, these risks must be thoroughly evaluated case-by-case.
  • (6) Whole-virus vaccines prepared by Merck Sharp and Dohme (West Point, Pa.) and Merrell-National Laboratories (Cincinnati, Ohio) and subunit vaccines prepared by Parke, Davis and Company (Detroit, Mich.) and Wyeth Laboratories (Philadelphia, Pa.) were given intramuscularly in concentrations of 800, 400, or 200 chick cell-agglutinating units per dose.
  • (7) The prophylactic effect of immunization with P. aeruginosa polyvalent corpuscular vaccine has been shown on the model of P. aeruginosa generalized chronic infection in mice with leukopenia induced by the intraperitoneal injection of cyclophosphamids.
  • (8) The data support inclusion of these residues in future CS protein vaccines.
  • (9) By vaccinating adult dogs in boarding kennels the morbidity rate dropped from 83.5% to 6.5% and the mortality rate from 4.1% to 0.5%.
  • (10) It is clear that before general release of a new living feline infectious enteritis vaccine, there must be satisfactory evidence that concurrent infection will not affect the safety of the modified antigen.In cats infected with feline infectious enteritis there appears to be a short period, coinciding with the onset of leucopaenia, during which they are highly infectious.
  • (11) The combination vaccine consisted of 12 Lf tetanus toxoid and 10 TCID50 vaccinia virus "MVA" preserved with gelatine and glucosamine.
  • (12) We evaluated the safety and efficacy of a conjugate vaccine that links the H. influenzae type b capsular polysaccharide to the outer-membrane protein complex (OMPC) of Neisseria meningitidis serogroup B.
  • (13) The litter size of vaccinated gilts was larger than that of the control gilts.
  • (14) The SNT and the I-ELISA indicated that the pigs responded to vaccination and challenge.
  • (15) The value of benefit-risk, benefit-cost, and cost-effectiveness analyses lies not in providing the definitive basis for a decision on vaccine use or evaluation.
  • (16) Injection of about four ImD 50 of vaccine intracerebrally produced a local immunity, resulting in an immediate kill of challenge organisms given 14 days later.
  • (17) For the purpose of studying the role of elastase and protease of Pseudomonas aeruginosa in bacterial infection in burns, the effects of the vaccines made from each enzyme, their toxoids and OEP on protection against infection in burned mice were studied.
  • (18) No vaccination reactions were noted, although most birds involved in the trials were carrying Mycoplasma spp.
  • (19) Serum from piglets of vaccinated sows had no more bactericidal activity than did sera from non-vaccinated sows.
  • (20) The purpose of this study was to investigate a tumor cell vaccine delivered via peripheral lymphatics as maintenance therapy after induction of remission with chemotherapy.

Words possibly related to "revaccinate"